DCF · Individual

Moderna (mRNA) Discounted Cash Flow

Built a full DCF model for Moderna, projecting free cash flows, WACC, and terminal value - stress-testing assumptions across bull, base, and bear scenarios.

FBE 421 - Financial Analysis & Valuation · Fall 2024 · USC Marshall

Final Submission

XLSX

Final Project - Part One: Valuation

Completed DCF valuation model & deliverable

↗

PDF

MRNA DCF Case Memo

Written analysis & investment recommendation

↗

PDF

Presentation Slides

DCF valuation presentation deck

↗

Case & Instructions

PDF

MRNA Case Fall 2024

Case study & assignment instructions

↗

PDF

MRNA DCF Template (PDF)

Template reference document

↗

Spreadsheet & Model

XLSX

MRNA DCF Template

DCF model with projections, WACC, and scenario analysis

↗

Supporting Data

CSV

DCF Valuation

Discounted cash flow calculations

↗

CSV

Revenue Build & FCF Forecast

Revenue projections & free cash flow forecast

↗

CSV

Comparable Companies

Peer company valuation multiples

↗

CSV

Benchmarking Analysis

Performance benchmarks vs. peers

↗

CSV

Sum of the Parts

Segment-level valuation breakdown

↗

CSV

Football Field

Valuation range summary chart data

↗

Let's Connect

USC Marshall & Leventhal '26 graduate · Currently: AI Specialist, FP&A at VXI Global Solutions.

soobranden@gmail.com linkedin.com/in/brandensoo San Francisco Bay Area, CA